Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
Saved in:
Main Author: | Juan Tamargo |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/f7f531e9dbad468e8cec0e108f45481d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
by: Juan Tamargo
Published: (2019) -
Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
by: Muhammad Shahzeb Khan, et al.
Published: (2019) -
Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs
by: Thomas A Zelniker, et al.
Published: (2019) -
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice
by: Giuseppe Rosano, et al.
Published: (2020) -
Corrigendum to: Pulmonary Hypertension in Heart Failure Patients
by: Sriram D Rao, et al.
Published: (2020)